Service des maladies infectieuses

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


2485 publications

 
Deciphering factors linked with reduced SARS-CoV-2 susceptibility in the Swiss HIV Cohort Study.
Abela I.A., Hauser A., Schwarzmüller M., Pasin C., Kusejko K., Epp S., Cavassini M., Battegay M., Rauch A., Calmy A. et al. The Journal of infectious diseases. Peer-reviewed.
 
Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3).
Amstutz A., Chammartin F., Audigé A., Eichenberger A.L., Braun D.L., Amico P., Stoeckle M.P., Hasse B., Papadimitriou-Olivgeris M., Manuel O. et al. The Journal of infectious diseases. Peer-reviewed.
 
Randomized, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route.
Audran R., Karoui O., Donnet L., Soumas V., Fares F., Lovis A., Noirez L., Cavassini M., Fayet-Mello A., Satti I. et al. The Journal of infection. Peer-reviewed.
 
Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy.
Begré L., Boyd A., Plissonnier M.L., Testoni B., Salazar-Vizcaya L., Suter-Riniker F., Scholtès C., Béguelin C., Rockstroh J.K., Günthard H.F. et al. The Journal of infectious diseases. Peer-reviewed.
 
Fecal microbiota transplantation for recurrent C. difficile infection can be the best therapeutic option in severely immunocompromised patients depending on a case-by-case assessment of the benefit/risk ratio.
Benech N., Cassir N., Galperine T., Alric L., Scanzi J., Sokol H., French Fecal Transplant Group (GFTF) Gastroenterology. Peer-reviewed.
 
Antifungal drug penetration in soft tissue abscesses: a comparative analysis.
Cancela Costa A., Kritikos A., Glampedakis E., Da Silva Pereira Clara J., Schaller F., Mercier T., Strasser R., Balmpouzis Z., Koutsokera A., Manuel O. et al. The Journal of antimicrobial chemotherapy. Peer-reviewed.
 
Weight, anthropometric and metabolic changes after discontinuing antiretroviral therapy containing tenofovir alafenamide (TAF) in people with HIV.
Damas J., Munting A., Fellay J., Haerry D., Marzolini C., Tarr P.E., Steffen A., Braun D.L., Stoeckle M., Bernasconi E. et al. Clinical infectious diseases. Peer-reviewed.
 
Implications of the 2023-2024 MPXV Clade I Outbreak in the DRC to Global Public Health.
Desai A.N., Koopmans M., Otter A., Grobusch M.P., Jokelainen P., Atkinson B., Cunha F., Valdoleiros S.R., Preda V.G., Fusco F.M. et al. Clinical microbiology and infection. Peer-reviewed.
 
Factors contributing to delayed initiation of appropriate antimicrobial treatment in patients with streptococcal bacteremia.
Fourre N., Guery B., Papadimitriou-Olivgeris M. Clinical infectious diseases. Peer-reviewed.
 
Evaluation of the HANDOC score and the 2023 ISCVID and ESC Duke clinical criteria for the diagnosis of infective endocarditis among patients with streptococcal bacteremia.
Fourre N., Zimmermann V., Senn L., Monney P., Tzimas G., Caruana G., Tozzi P., Kirsch M., Guery B., Papadimitriou-Olivgeris M. Clinical infectious diseases. Peer-reviewed.
 
Human herpesvirus-6, HHV-8 and parvovirus B19 after allogeneic hematopoietic cell transplant: the lesser-known viral complications.
Kampouri E., Little J.S., Crocchiolo R., Hill J.A. Current opinion in infectious diseases. Peer-reviewed.
 
Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study.
Lumbreras Areta M., Migliorelli Falcone F.E., Rudin C., Kahlert C.R., Paioni P., Baumann M.U., Darling K., Polli C., Martinez de Tejada B. HIV medicine. Peer-reviewed.
 
Role of source control in critically ill candidemic patients: a multicenter retrospective study.
Marangos M., Ioannou P., Senn L., Spiliopoulou A., Tzalis S., Kolonitsiou F., Valta M., Kokkini S., Pagani J.L., Stafylaki D. et al. Infection. Peer-reviewed.
 
Donor-derived infections: The Swiss perspective.
Mueller N.J., Manuel O., Hirzel C., Swiss Transplant Cohort Study (STCS) Transplant infectious disease. Peer-reviewed.
 
Impact of hormonal therapy on HIV-1 immune markers in cis women and gender minorities.
Pasin C., Nuñez D.G., Kusejko K., Hachfeld A., Buvelot H., Cavassini M., Damonti L., Fux C., de Tejada B.M., Notter J. et al. HIV medicine. Peer-reviewed.
 
Care interruptions and mortality among adults in Europe and North America: a collaborative analysis of cohort studies.
Trickey A., Zhang L., Rentsch C.T., Pantazis N., Izquierdo R., Antinori A., Leierer G., Burkholder G., Cavassini M., Palacio-Vieira J. et al. AIDS. Peer-reviewed.
 
Time Trends in Causes of Death in People with HIV: Insights from the Swiss HIV Cohort Study.
Weber MSR, Duran Ramirez J.J., Hentzien M., Cavassini M., Bernasconi E., Hofmann E., Furrer H., Kovari H., Stöckle M., Schmid P. et al. Clinical infectious diseases. Peer-reviewed.
 
Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual.
Yeoh K., Lass-Flörl C., Lamoth F., Slavin M.A., Williams E., Neofytos D. Transplant infectious disease. Peer-reviewed.
 
Genetic diversity from proviral DNA as a proxy for time since HIV-1 infection.
Zeeb M., Frischknecht P., Huber M., Schenkel C.D., Neumann K., Leeman C., Notter J., Rauch A., Stöckle M., Cavassini M. et al. The Journal of infectious diseases. Peer-reviewed.
Predictors of Mortality of Streptococcal Bacteremia and the Role of Infectious Diseases Consultation: A Retrospective Cohort Study.
Fourre N., Zimmermann V., Senn L., Aruanno M., Guery B., Papadimitriou-Olivgeris M., 2024/06/14. Clinical infectious diseases, 78 (6) pp. 1544-1550. Peer-reviewed.
 
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease.
Hoenigl M., Arastehfar A., Arendrup M.C., Brüggemann R., Carvalho A., Chiller T., Chen S., Egger M., Feys S., Gangneux J-P et al., 2024/06/13. Clinical microbiology reviews, 37 (2) pp. e0007423. Peer-reviewed.
Association of persistent positive blood cultures and infective endocarditis: A cohort study among patients with suspected infective endocarditis.
Teixeira Antunes A., Monney P., Tzimas G., Tozzi P., Kirsch M., Guery B., Papadimitriou-Olivgeris M., 2024/06. International journal of infectious diseases, 143 p. 107022. Peer-reviewed.
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV.
Thoueille P., Saldanha S.A., Schaller F., Choong E., Veuve F., Munting A., Cavassini M., Braun D., Günthard H.F., Duran Ramirez J.J. et al., 2024/06. Clinical pharmacology and therapeutics, 115 (6) pp. 1450-1459. Peer-reviewed.
 
The Burden of Invasive Fungal Disease Following Chimeric Antigen Receptor T-Cell Therapy and Strategies for Prevention.
Little J.S., Kampouri E., Friedman D.Z., McCarty T., Thompson G.R., Kontoyiannis D.P., Vazquez J., Baddley J.W., Hammond S.P., 2024/06. Open forum infectious diseases, 11 (6) pp. ofae133. Peer-reviewed.
Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity.
Brunet-Ratnasingham E., Morin S., Randolph H.E., Labrecque M., Bélair J., Lima-Barbosa R., Pagliuzza A., Marchitto L., Hultström M., Niessl J. et al., 2024/05/16. Nature communications, 15 (1) p. 4177. Peer-reviewed.
 
Cardiovascular Disease Risk Factor Control in People With and Without HIV.
Silverberg M.J., Levine T.M., Lea A.N., Williams A.E., Alexeeff S.E., Bryant K., Cavassini M., Flamm J.A., Hare C.B., Ingle S.M. et al., 2024/05/15. Clinical infectious diseases, 78 (5) pp. 1264-1271. Peer-reviewed.
 
Herpes simplex encephalitis due to a mutation in an E3 ubiquitin ligase.
Bibert S., Quinodoz M., Perriot S., Krebs F.S., Jan M., Malta R.C., Collinet E., Canales M., Mathias A., Faignart N. et al., 2024/05/10. Nature communications, 15 (1) p. 3969. Peer-reviewed.
 
Development and evaluation of an artificial intelligence for bacterial growth monitoring in clinical bacteriology.
Jacot D., Gizha S., Orny C., Fernandes M., Tricoli C., Marcelpoil R., Prod'hom G., Volle J-M, Greub G., Croxatto A., 2024/05/08. Journal of clinical microbiology, 62 (5) pp. e0165123. Peer-reviewed.
Adapting response to a measles outbreak in a context of high vaccination and breakthrough cases: an example from Vaud, Switzerland, January to March 2024.
Cassini A., Cobuccio L., Glampedakis E., Cherpillod P., Crisinel P.A., Pérez-Rodríguez F.J., Attinger M., Bachelin D., Tessemo M.N., Maeusezahl M. et al., 2024/05. Euro surveillance, 29 (22). Peer-reviewed.
Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update.
Portillo V., Ragozzino S., Stavropoulou E., El-Khoury C., Bochud P.Y., Lamoth F., Khanna N., Neofytos D., 2024/05. Open forum infectious diseases, 11 (5) pp. ofae201. Peer-reviewed.
 
Characterization and Determinants of Long-Term Immune Recovery Under Suppressive Antiretroviral Therapy.
Turk T., Labarile M., Braun D.L., Rauch A., Stöckle M., Cavassini M., Hoffmann M., Calmy A., Bernasconi E., Notter J. et al., 2024/05/01. Journal of acquired immune deficiency syndromes, 96 (1) pp. 68-76. Peer-reviewed.
Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS).
Couchepin J., Reinhold I., Kronig I., Guidi M., Buclin T., Schreiber P.W., Neofytos D., Lamoth F., Fungal Infection Network of Switzerland (FUNGINOS), 2024/05. Open forum infectious diseases, 11 (5) pp. ofae223. Peer-reviewed.
 
Surgical site infections after kidney transplantation are independently associated with graft loss.
Schreiber P.W., Hoessly L.D., Boggian K., Neofytos D., van Delden C., Egli A., Dickenmann M., Hirzel C., Manuel O., Koller M. et al., 2024/05. American journal of transplantation, 24 (5) pp. 795-802. Peer-reviewed.
 
What do We Know about Cryptic Aspergillosis?
Geremia N., Giovagnorio F., Colpani A., De Vito A., Caruana G., Meloni M.C., Madeddu G., Panese S., Parisi S.G., 2024/04/28. Microorganisms, 12 (5). Peer-reviewed.
Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL'HIV open-label, factorial randomised controlled trial.
Marinosci A., Sculier D., Wandeler G., Yerly S., Stoeckle M., Bernasconi E., Braun D.L., Vernazza P., Cavassini M., Buzzi M. et al., 2024/04/15. Swiss medical weekly, 154 p. 3762. Peer-reviewed.
Evaluation of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Criteria in a Multicenter Cohort of Patients With Suspected Infective Endocarditis.
Papadimitriou-Olivgeris M., Monney P., Frank M., Tzimas G., Tozzi P., Kirsch M., Van Hemelrijck M., Bauernschmitt R., Epprecht J., Guery B. et al., 2024/04/10. Clinical infectious diseases, 78 (4) pp. 949-955. Peer-reviewed.
 
Infections respiratoires : quand un cheval est en fait un zèbre [Respiratory infections: when a horse is actually a zebra]
Cancela Costa A., Cobuccio L., Monsalve L., Pallanza M., Teixeira Antunes A., Manuel O., Desgranges F., 2024/04/10. Revue medicale suisse, 20 (869) pp. 734-738. Peer-reviewed.
 
La révolution des médicaments à action prolongée.
Kaufmann D., Kaiser L., 2024/04/10. Revue medicale suisse, 20 (869) pp. 731-732. Peer-reviewed.
 
Lutte contre l’antibiorésistance : audits des pratiques pour cibler les actions [Combating antimicrobial resistance: audits of practices to target actions]
Valladares P.U., Perrottet N., Senn L., Moulin E., 2024/04/10. Revue medicale suisse, 20 (869) pp. 739-742. Peer-reviewed.
 
Prophylaxie pré-exposition au VIH : les médecins ne sont pas préparés [HIV pre-exposure prophylaxis: physicians are not prepared]
Badoux M., Damas J., Cobos Manuel I., Cavassini M., Munting A., 2024/04/10. Revue medicale suisse, 20 (869) pp. 748-755. Peer-reviewed.
 
Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020.
Hosseini-Moghaddam S.M., Kothari S., Humar A., Albasata H., Yetmar Z.A., Razonable R.R., Neofytos D., D'Asaro M., Boggian K., Hirzel C. et al., 2024/04. American journal of transplantation, 24 (4) pp. 653-668. Peer-reviewed.
 
Current management of SARS-CoV-2 infection in solid organ transplant recipients: Experience derived from an ESGICH-ESOT survey.
Visentin A., Pickavance E., San-Juan R., Grossi P.A., Manuel O., Aguado J.M., 2024/04. Transplant infectious disease, 26 (2) pp. e14252. Peer-reviewed.
 
Heterogeneity in practices to reduce the risk of transmission of Clostridioides difficile in healthcare settings: a survey of ESCMID Study Group for Clostridioides difficile (ESGCD) members.
Khanafer N.L., Fitzpatrick F., Barbut F., Krutova M., Davies K., Guery B., Vanhems P., 2024/04. European journal of clinical microbiology & infectious diseases, 43 (4) pp. 785-789. Peer-reviewed.
 
PCR diagnostic platforms for non-Aspergillus mold infections: ready for routine implementation in the clinic?
Lamoth F., Kontoyiannis D.P., 2024/04. Expert review of molecular diagnostics, 24 (4) pp. 273-282. Peer-reviewed.
 
Update on microbiota-derived therapies for recurrent Clostridioides difficile infections.
Benech N., Barbut F., Fitzpatrick F., Krutova M., Davies K., Druart C., Cordaillat-Simmons M., Heritage J., Guery B., Kuijper E. et al., 2024/04. Clinical microbiology and infection, 30 (4) pp. 462-468. Peer-reviewed.
 
Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy.
Royo-Cebrecos C., Laporte-Amargós J., Peña M., Ruiz-Camps I., Garcia-Vidal C., Abdala E., Oltolini C., Akova M., Montejo M., Mikulska M. et al., 2024/03/30. Microorganisms, 12 (4). Peer-reviewed.
Investigations of an increased incidence of non-Aspergillus invasive mould infections in an onco-haematology unit.
Stavropoulou E., Huguenin A., Caruana G., Opota O., Perrottet N., Blanc D.S., Grandbastien B., Senn L., Bochud P.Y., Lamoth F., 2024/03/26. Swiss medical weekly, 154 p. 3730. Peer-reviewed.
 
Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape.
Kampouri E., Handley G., Hill J.A., 2024/03/24. Viruses, 16 (4). Peer-reviewed.
 
Evaluation of the 2023 Duke-ISCVID and 2023 Duke-ESC Clinical Criteria for the Diagnosis of Infective Endocarditis in a Multicenter Cohort of Patients With Staphylococcus aureus Bacteremia.
Papadimitriou-Olivgeris M., Monney P., Frank M., Tzimas G., Tozzi P., Kirsch M., Van Hemelrijck M., Bauernschmitt R., Epprecht J., Guery B. et al., 2024/03/20. Clinical infectious diseases, 78 (3) pp. 655-662. Peer-reviewed.
 
Eyes Wide Shut: A Cohort Study Questioning the Role of Fundoscopy in Infective Endocarditis Diagnosis.
Stavropoulou E., Guery B., Tzimas G., Guex-Crosier Y., Hoogewoud F., Tozzi P., Kirsch M., Monney P., Papadimitriou-Olivgeris M., 2024/03/20. Clinical infectious diseases, 78 (3) pp. 663-666. Peer-reviewed.
 
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol.
Hentzien M., Bonnet F., Bernasconi E., Biver E., Braun D.L., Munting A., Leuzinger K., Leleux O., Musardo S., Prendki V. et al., 2024/03/19. BMC infectious diseases, 24 (1) p. 329. Peer-reviewed.
 
Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia.
Benlarbi M., Richard J., Bourassa C., Tolbert W.D., Chartrand-Lefebvre C., Gendron-Lepage G., Sylla M., El-Far M., Messier-Peet M., Guertin C. et al., 2024/03/14. The Journal of infectious diseases, 229 (3) pp. 763-774. Peer-reviewed.
Serial monitoring of pancreatic stone protein for the detection of sepsis in intensive care unit patients with complicated abdominal surgery: A prospective, longitudinal cohort study.
Filippidis P., Hovius L., Tissot F., Orasch C., Flückiger U., Siegemund M., Pagani J.L., Eggimann P., Marchetti O., Lamoth F. et al., 2024/03/11. Journal of critical care, 82 p. 154772. Peer-reviewed.
 
Lung and sinus fungal infection imaging in immunocompromised patients.
Lamoth F., Prakash K., Beigelman-Aubry C., Baddley J.W., 2024/03. Clinical microbiology and infection, 30 (3) pp. 296-305. Peer-reviewed.
 
Systematic scoping review of automated systems for the surveillance of healthcare-associated bloodstream infections related to intravascular catheters.
Lotfinejad N., Januel J.M., Tschudin-Sutter S., Schreiber P.W., Grandbastien B., Damonti L., Lo Priore E., Scherrer A., Harbarth S., Catho G. et al., 2024/02/28. Antimicrobial resistance and infection control, 13 (1) p. 25. Peer-reviewed.
Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis.
Fournelle D., Mostefai F., Brunet-Ratnasingham E., Poujol R., Grenier J.C., Gálvez J.H., Pagliuzza A., Levade I., Moreira S., Benlarbi M. et al., 2024/02/23. Viruses, 16 (3). Peer-reviewed.
Evaluation of the Clinical Rule for Endocarditis in the Emergency Department Among Patients With Suspected Infective Endocarditis.
Papadimitriou-Olivgeris M., Monney P., Carron P.N., Tzimas G., Beysard N., Tozzi P., Kirsch M., Guery B., 2024/02/20. Journal of the American Heart Association, 13 (4) pp. e032745. Peer-reviewed.
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers.
Gasca-Capote C., Lian X., Gao C., Roseto I.C., Jiménez-León M.R., Gladkov G., Camacho-Sojo M.I., Pérez-Gómez A., Gallego I., Lopez-Cortes L.E. et al., 2024/02/20. The Journal of clinical investigation, 134 (8). Peer-reviewed.
 
Multicentric evaluation of a specific intrathecal anti-Treponema pallidum IgG index as a diagnostic biomarker of neurosyphilis: results from a retro-prospective case-control study.
Alberto C., Lambeng N., Deffert C., Breville G., Gayet-Ageron A., Lalive P., Calmy A., Coste A., Papadimitriou-Olivgeris M., Braun D. et al., 2024/02/19. Sexually transmitted infections, 100 (2) pp. 63-69. Peer-reviewed.
Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.
Manuel O., Laager M., Hirzel C., Neofytos D., Walti L.N., Hoenger G., Binet I., Schnyder A., Stampf S., Koller M. et al., 2024/02/17. Clinical infectious diseases, 78 (2) pp. 312-323. Peer-reviewed.
 
Study to evaluate the future data compilation for the Swiss Consumer Sentiment Index
Lutz Georg, Wernli Boris, Antal Erika, Lipps Oliver, Legler Victor, Kaufmann Daniel, Burri Marc, 2024/02/15., Staatssekretariat für Wirtschaft SECO, Bern, Switzerland. Grundlagen für die Wirtschaftspolitik Nr. 43..
Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients.
Schrijver I.T., Herderschee J., Théroude C., Kritikos A., Leijte G., Le Roy D., Brochut M., Chiche J.D., Perreau M., Pantaleo G. et al., 2024/02/08. Cells, 13 (4). Peer-reviewed.
 
Prevalence of Infective Endocarditis among Patients with Staphylococcus aureus Bacteraemia and Bone and Joint Infections.
Papadimitriou-Olivgeris M., Guery B., Monney P., Senn L., Steinmetz S., Boillat-Blanco N., 2024/02/06. Microorganisms, 12 (2). Peer-reviewed.
 
Upc2-mediated mechanisms of azole resistance in Candida auris.
Li J., Aubry L., Brandalise D., Coste A.T., Sanglard D., Lamoth F., 2024/02/06. Microbiology spectrum, 12 (2) pp. e0352623. Peer-reviewed.
Estimating the return on investment of selected infection prevention and control interventions in healthcare settings for preparing against novel respiratory viruses: modelling the experience from SARS-CoV-2 among health workers.
Özçelik E., Lerouge A., Cecchini M., Cassini A., Allegranzi B., 2024/02. EClinicalMedicine, 68 p. 102388. Peer-reviewed.
Global distribution modelling of a conspicuous Gondwanian soil protist reveals latitudinal dispersal limitation and range contraction in response to climate warming
Bruni Estelle P., Rusconi Olivia, Broennimann Olivier, Adde Antoine, Jauslin Raphaël, Krashevska Valentyna, Kosakyan Anush, Armynot du Châtelet Eric, Alcino João P. B., Beyens Louis et al., 2024/02. Diversity and Distributions, 30 (2) pp. e13779. Peer-reviewed.
Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures.
Thoueille P., Cavassini M., Guidi M., Buclin T., Girardin F.R., Decosterd L.A., Marzolini C., 2024/02. Open forum infectious diseases, 11 (2) pp. ofae023. Peer-reviewed.
Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy.
Begré L., Boyd A., Salazar-Vizcaya L., Suter-Riniker F., Béguelin C., Rockstroh J.K., Günthard H.F., Calmy A., Cavassini M., Stöckle M. et al., 2024/02. HIV medicine, 25 (2) pp. 291-298. Peer-reviewed.
 
Re: 'The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes' by Stabholz et al.
van Prehn J., Skinner A.M., Krutova M., Guery B., 2024/02. Clinical microbiology and infection, 30 (2) pp. 261-262. Peer-reviewed.
Risk of embolic events before and after antibiotic treatment initiation among patients with left-side infective endocarditis.
Papadimitriou-Olivgeris M., Guery B., Ianculescu N., Auberson D., Tozzi P., Kirsch M., Monney P., 2024/02. Infection, 52 (1) pp. 117-128. Peer-reviewed.
 
Which trial do we need? A sequential multiple assignment randomized trial to determine the optimal Clostridioides difficile treatment sequence.
van Prehn J., van Werkhoven C.H., Skinner A.M., Guery B., Dubberke E.R., Kuijper E.J., 2024/02. Clinical microbiology and infection, 30 (2) pp. 165-169. Peer-reviewed.
Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort Data.
Berton M., Bettonte S., Stader F., Decosterd L., Tarr P.E., Livio F., Cavassini M., Braun D.L., Kusejko K., Hachfeld A. et al., 2024/01/25. Clinical infectious diseases, 78 (1) pp. 98-110. Peer-reviewed.
Immunogenicity of High-Dose Versus MF59-Adjuvanted Versus Standard Influenza Vaccine in Solid Organ Transplant Recipients: The Swiss/Spanish Trial in Solid Organ Transplantation on Prevention of Influenza (STOP-FLU Trial).
Mombelli M., Neofytos D., Huynh-Do U., Sánchez-Céspedes J., Stampf S., Golshayan D., Dahdal S., Stirnimann G., Schnyder A., Garzoni C. et al., 2024/01/25. Clinical infectious diseases, 78 (1) pp. 48-56. Peer-reviewed.
 
PLUS-IS-LESS project: Procalcitonin and Lung UltraSonography-based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: study protocol for a pragmatic stepped-wedge cluster-randomized trial.
Bessat C., Bingisser R., Schwendinger M., Bulaty T., Fournier Y., Della Santa V., Pfeil M., Schwab D., Leuppi J.D., Geigy N. et al., 2024/01/25. Trials, 25 (1) p. 86. Peer-reviewed.
Enhanced detection of antigen-specific T cells by a multiplexed AIM assay.
Lemieux A., Sannier G., Nicolas A., Nayrac M., Delgado G.G., Cloutier R., Brassard N., Laporte M., Duchesne M., Sreng Flores A.M. et al., 2024/01/22. Cell reports methods, 4 (1) p. 100690. Peer-reviewed.
 
Estimation of Improvements in Mortality in Spectrum Among Adults With HIV Receiving Antiretroviral Therapy in High-Income Countries.
Trickey A., Glaubius R., Pantazis N., Zangerle R., Wittkop L., Vehreschild J., Grabar S., Cavassini M., Teira R., d'Arminio Monforte A. et al., 2024/01/01. Journal of acquired immune deficiency syndromes, 95 (1S) pp. e89-e96. Peer-reviewed.
External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older.
Hentzien M., Frossard J., Kouyos R., Prendki V., Damas J., Hofmann E., Braun D., Schmid P., Bernasconi E., Ragozzino S. et al., 2024/01. HIV medicine, 25 (1) pp. 72-82. Peer-reviewed.
 
Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.
Brune J.E., Dickenmann M., Sidler D., Walti L.N., Golshayan D., Manuel O., Haidar F., Neofytos D., Schnyder A., Boggian K. et al., 2024. Frontiers in medicine, 11 p. 1329778. Peer-reviewed.
Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort.
Hovaguimian F., Kouyos R.D., Kusejko K., Schmidt A.J., Tarr P.E., Bernasconi E., Braun D.L., Calmy A., Notter J., Stoeckle M. et al., 2024/01. HIV medicine, 25 (1) pp. 117-128. Peer-reviewed.
Infective aortitis and subacute myocarditis due to Campylobacter fetus.
Lenherr A., Boughdad S., Prior J.O., Lalonde M.N., Filippidis P., 2024/01. International journal of infectious diseases, 138 pp. 113-114. Peer-reviewed.
Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study.
Baumann L., Braun D.L., Cavassini M., Stoeckle M., Bernasconi E., Schmid P., Calmy A., Haerry D., Béguelin C., Fux C.A. et al., 2024/01. Liver international, 44 (1) pp. 169-179. Peer-reviewed.
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
Thoueille P., Saldanha S.A., Schaller F., Choong E., Munting A., Cavassini M., Braun D., Günthard H.F., Kusejko K., Surial B. et al., 2024/01. The Lancet regional health. Europe, 36 p. 100793. Peer-reviewed.
Diversity and evolution of an abundant ICEclc family of integrative and conjugative elements in Pseudomonas aeruginosa.
Benigno V., Carraro N., Sarton-Lohéac G., Romano-Bertrand S., Blanc D.S., van der Meer J.R., 2023/12/20. mSphere, 8 (6) pp. e0051723. Peer-reviewed.
 
Patient Stratification for Antibiotic Prescriptions Based on the Bound-Free Phase Detection Immunoassay of C-Reactive Protein in Serum Samples.
Johannsen B., Baumgartner D., Karpíšek M., Stejskal D., Boillat-Blanco N., Knüsli J., Panning M., Paust N., Zengerle R., Mitsakakis K., 2023/12/03. Biosensors, 13 (12) p. 1009. Peer-reviewed.
Core genome multilocus sequence typing of Clostridioides difficile to investigate transmission in the hospital setting.
Filippidis P., Senn L., Poncet F., Grandbastien B., Prod'hom G., Greub G., Guery B., Blanc D.S., 2023/12. European journal of clinical microbiology & infectious diseases, 42 (12) pp. 1469-1476. Peer-reviewed.
Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in Switzerland.
Zeeb M., Tepekule B., Kusejko K., Reiber C., Kälin M., Bartl L., Notter J., Furrer H., Hoffmann M., Hirsch H.H. et al., 2023/11/11. Clinical infectious diseases, 77 (9) pp. 1303-1311. Peer-reviewed.
 
Prise en charge pratique de l’affection post-Covid-19. Mise à jour et illustration par des situations cliniques [Practical management of post-COVID-19 condition. Update and illustration by clinical situations]
Kokkinakis I., Saubade M., Tzartzas K., De Vallière S., Duquenne C., Allali G., Regamey F., Favrat B., 2023/11/08. Revue medicale suisse, 19 (849) pp. 2094-2102. Peer-reviewed.
Occurrence of Aspergillus fumigatus azole resistance in soils from Switzerland.
Schürch S., Gindro K., Schnee S., Dubuis P.H., Codina J.M., Wilhelm M., Riat A., Lamoth F., Sanglard D., 2023/11/06. Medical mycology, 61 (11) pp. myad110. Peer-reviewed.
 
An Unusual Cause of Severe Granulomatous Hepatitis and Jaundice.
Coukos A., Uldry E., Meylan S., Schmidt S., Fasquelle F., Sempoux C., Fraga M., 2023/11/01. The American journal of gastroenterology, 118 (11) p. 1920. Peer-reviewed.
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2).
Griessbach A., Chammartin F., Abela I.A., Amico P., Stoeckle M.P., Eichenberger A.L., Hasse B., Braun D.L., Schuurmans M.M., Müller T.F. et al., 2023/11. Open forum infectious diseases, 10 (11) pp. ofad536. Peer-reviewed.
 
Burden of seasonal influenza in the Swiss adult population during the 2016/2017-2018/2019 influenza seasons.
Ammann D., Bilger J., Loiacono M.M., Oberle S.G., Dounas A., Manuel O., Pletscher M., 2023/11. Influenza and other respiratory viruses, 17 (11) pp. e13218. Peer-reviewed.
 
COVID-19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)-T-cell therapy.
Kampouri E., Hill J.A., Dioverti V., 2023/11. Transplant infectious disease, 25 Suppl 1 pp. e14144. Peer-reviewed.
COVID-19 isolation measures did not prevent vancomycin-resistant enterococci transmissions.
Van Singer M., Senn L., Blanc D.S., Koenig I., Simon C., Grandbastien B., 2023/11. The Journal of hospital infection, 141 pp. 129-131. Peer-reviewed.
Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies.
Kampouri E., Little J.S., Rejeski K., Manuel O., Hammond S.P., Hill J.A., 2023/11. Transplant infectious disease, 25 (Suppl 1) pp. e14157. Peer-reviewed.
 
Remise des autotests VIH en pharmacie d’officine. État des lieux et recommandations de pratique pour une collaboration interprofessionnelle [HIV self-tests in community pharmacies Inventory and practice recommendations for interprofessional collaborations]
Rousseau M., Solh Dost S., Santos B., Gauthier R., Cavassini M., Calmy A., Schneider M., 2023/10/25. Revue medicale suisse, 19 (847) pp. 2017-2020. Peer-reviewed.
 
Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action
Sartelli Massimo, Barie Philip S., Coccolini Federico, Abbas Mohamed, Abbo Lilian M., Abdukhalilova Gulnora K., Abraham Yishak, Abubakar Salisu, Abu-Zidan Fikri M., Adebisi Yusuff Adebayo et al., 2023/10/16. World Journal of Emergency Surgery, 18 (1).
 
Infections postchirurgie artérielle des membres inférieurs : peut-on mieux faire? [Surgical site infection after lower limb arterial reconstruction: can we improve prevention?]
Catho G., Moulin E., Sommerstein R., Deslarzes C., Arts L., Danzer D., Haller C., Berthod D., 2023/10/11. Revue medicale suisse, 19 (845) pp. 1824-1829. Peer-reviewed.
Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ART.
Banga R., Procopio F.A., Lana E., Gladkov G.T., Roseto I., Parsons E.M., Lian X., Armani-Tourret M., Bellefroid M., Gao C. et al., 2023/10/11. Cell host & microbe, 31 (10) pp. 1714-1731.e9. Peer-reviewed.
 
Hear my voice: involving patients in Clostridioides difficile infection research.
Strawbridge J., Heritage J., Krůtová M., Guery B., Davies K., Fitzpatrick F., Freeman J., 2023/10. Clinical microbiology and infection, 29 (10) pp. 1222-1224. Peer-reviewed.
Impact of COVID-19 on long-term lung function in lung transplant recipients: A single-center retrospective cohort study.
Touilloux B., Papadimitriou-Olivgeris M., Bongard C., Mansouri N., Ioakeim F., Manuel O., Koutsokera A., Aubert J.D., Casutt A., 2023/10. Transplant infectious disease, 25 (5) pp. e14151. Peer-reviewed.
Impact of thoracoabdominal imaging on diagnosis and management in patients with suspected infective endocarditis.
Papadimitriou-Olivgeris M., Monney P., Rotzinger D.C., Kamani C.H., Fahrni G., Prior J.O., Ianculescu N., Messaoudi Y., Tozzi P., Kirsch M. et al., 2023/10. European journal of internal medicine, 116 pp. 82-88. Peer-reviewed.
Legionnaires' disease in Switzerland: rationale and study protocol of a prospective national case-control and molecular source attribution study (SwissLEGIO).
Fischer F.B., Bigler M., Mäusezahl D., Hattendorf J., Egli A., Julian T.R., Rölli F., Gaia V., Wymann M., Fridez F. et al., 2023/10. Infection, 51 (5) pp. 1467-1479. Peer-reviewed.
 
Nanomotion technology in combination with machine learning: a new approach for a rapid antibiotic susceptibility test for Mycobacterium tuberculosis.
Vocat A., Sturm A., Jóźwiak G., Cathomen G., Świątkowski M., Buga R., Wielgoszewski G., Cichocka D., Greub G., Opota O., 2023/10. Microbes and infection, 25 (7) p. 105151. Peer-reviewed.
Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians.
Casutt A., Lamoth F., Lortholary O., Prior J.O., Tonglet A., Manuel O., Bergeron A., Beigelman-Aubry C., 2023/09/30. European respiratory review, 32 (169). Peer-reviewed.
 
Ticks and Chlamydia-Related Bacteria in Swiss Zoological Gardens Compared to in Contiguous and Distant Control Areas.
Vanat V., Aeby S., Greub G., 2023/09/30. Microorganisms, 11 (10) p. 2468. Peer-reviewed.
 
Validation of sTREM-1 and IL-6 based algorithms for outcome prediction of COVID-19.
Van Singer M., Brahier T., Koch J., Hugli P.O., Weckman A.M., Zhong K., Kain T.J., Leligdowicz A., Bernasconi E., Ceschi A. et al., 2023/09/26. BMC infectious diseases, 23 (1) p. 630. Peer-reviewed.
 
Spontaneous Aberrant Bodies Formation in Human Pneumocytes Infected with Estrella lausannensis.
Rovero A., Kebbi-Beghdadi C., Greub G., 2023/09/22. Microorganisms, 11 (10) p. 2368. Peer-reviewed.
Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery.
Stavropoulou E., Atkinson A., Eisenring M.C., Fux C.A., Marschall J., Senn L., Troillet N., 2023/09/19. Antimicrobial resistance and infection control, 12 (1) p. 105. Peer-reviewed.
 
Financial significance of sepsis coding deficiencies for a tertiary center.
Agri Fabio, Durr Dimitri, Despraz Jérémie, Niemi Tapio, Dami Fabrice, Roth-Kleiner Matthias, Calandra Thierry, Meylan Sylvain, 2023/09/15. dans Joint Annual Meeting of the Swiss Society for Infectious Diseases, the Swiss Society for Hospital Hygiene and the Swiss Society of Tropical and Travel Medicine. Zurich. 2023. Peer-reviewed.
Humoral Responses Elicited after a Fifth Dose of SARS-CoV-2 mRNA Bivalent Vaccine.
Tauzin A., Beaudoin-Bussières G., Benlarbi M., Nayrac M., Bo Y., Gendron-Lepage G., Medjahed H., Perreault J., Gokool L., Arlotto P. et al., 2023/09/15. Viruses, 15 (9) p. 1926. Peer-reviewed.
Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4+ and CD8+ T cells.
Dubé M., Tastet O., Dufour C., Sannier G., Brassard N., Delgado G.G., Pagliuzza A., Richard C., Nayrac M., Routy J.P. et al., 2023/09/13. Cell host & microbe, 31 (9) pp. 1507-1522.e5. Peer-reviewed.
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy.
Surial B., Chammartin F., Damas J., Calmy A., Haerry D., Stöckle M., Schmid P., Bernasconi E., Fux C.A., Tarr P.E. et al., 2023/09/11. Clinical infectious diseases, 77 (5) pp. 729-737. Peer-reviewed.
 
IVDR: Analysis of the Social, Economic, and Practical Consequences of the Application of an Ordinance of the In Vitro Diagnostic Ordinance in Switzerland.
Coste A.T., Egli A., Schrenzel J., Nickel B., Zbinden A., Lienhard R., Dumoulin A., Risch M., Greub G., Coordinated Clinical Commission of Microbiology (CCCM), 2023/09/11. Diagnostics, 13 (18). Peer-reviewed.
 
Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018.
Jaha B., Schenkel C.D., Jörimann L., Huber M., Zaheri M., Neumann K., Leemann C., Calmy A., Cavassini M., Kouyos R.D. et al., 2023/09/05. The Journal of antimicrobial chemotherapy, 78 (9) pp. 2323-2334. Peer-reviewed.
 
'Which trial do we need? Culture of preservation fluid in abdominal organ transplant recipients' Author's reply.
Manuel O., van den Bogaart L., Mueller N.J., Neofytos D., 2023/09. Clinical microbiology and infection, 29 (9) p. 1204. Peer-reviewed.
Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor-containing regimen.
Marzolini C., Cavassini M., Braun D.L., Hachfeld A., Bernasconi E., Calmy A., Schmid P., Battegay M., Elzi L., Swiss HIV Cohort Study, 2023/09. British journal of clinical pharmacology, 89 (9) pp. 2739-2746. Peer-reviewed.
Global knowledge gaps on antimicrobial resistance in the human health sector: A scoping review.
Hamers R.L., Dobreva Z., Cassini A., Tamara A., Lazarus G., Asadinia K.S., Burzo S., Olaru I.D., Dona D., Emdin F. et al., 2023/09. International journal of infectious diseases, 134 pp. 142-149. Peer-reviewed.
 
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9).
Cesaro S., Mikulska M., Hirsch H.H., Styczynski J., Meylan S., Cordonnier C., Navarro D., von Lilienfeld-Toal M., Mehra V., Marchesi F. et al., 2023/09. Leukemia, 37 (9) pp. 1933-1938. Peer-reviewed.
 
Predictive performance of automated surveillance algorithms for intravascular catheter bloodstream infections: a systematic review and meta-analysis.
Januel J.M., Lotfinejad N., Grant R., Tschudin-Sutter S., Schreiber P.W., Grandbastien B., Jent P., Lo Priore E., Scherrer A., Harbarth S. et al., 2023/08/31. Antimicrobial resistance and infection control, 12 (1) p. 87. Peer-reviewed.
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice.
Rossier L., Matter C., Burri E., Galperine T., Hrúz P., Juillerat P., Schoepfer A., Vavricka S.R., Zahnd N., Décosterd N. et al., 2023/08/25. Swiss medical weekly, 153 p. 40100. Peer-reviewed.
 
Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.
Galperine T., Choi Y., Pagani J.L., Kritikos A., Papadimitriou-Olivgeris M., Méan M., Scherz V., Opota O., Greub G., Guery B. et al., 2023/08/18. BMC infectious diseases, 23 (1) p. 537. Peer-reviewed.
Role of Cerebral Imaging on Diagnosis and Management in Patients With Suspected Infective Endocarditis.
Papadimitriou-Olivgeris M., Guery B., Ianculescu N., Dunet V., Messaoudi Y., Pistocchi S., Tozzi P., Kirsch M., Monney P., 2023/08/14. Clinical infectious diseases, 77 (3) pp. 371-379. Peer-reviewed.
 
Sexual Behaviour and STI Incidence in Sexually Active MSM Living With HIV in Times of COVID-19.
Mugglin C., Hamusonde K., Salazar-Vizcaya L., Kusejko K., Nicca D., Haerry D., Braun D.L., Stoeckle M., Kouyos R., Calmy A. et al., 2023/08. Open forum infectious diseases, 10 (8) pp. ofad399. Peer-reviewed.
 
The role of early defervescence in ruling out infective endocarditis: a cohort study.
Stavropoulou E., Guery B., Ianculescu N., Tozzi P., Kirsch M., Monney P., Papadimitriou-Olivgeris M., 2023/08. Clinical microbiology and infection, 29 (8) pp. 1087.e5-1087.e8. Peer-reviewed.
Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study.
Paioni P., Aebi-Popp K., Martinez de Tejada B., Rudin C., Bernasconi E., Braun D.L., Kouyos R., Wagner N., Crisinel P.A., Güsewell S. et al., 2023/08. The Lancet regional health. Europe, 31 p. 100656. Peer-reviewed.
 
Viral-associated Pulmonary Aspergillosis: Have We Finally Overcome the Debate of Colonization versus Infection?
Albrich W.C., Lamoth F., 2023/08/01. American journal of respiratory and critical care medicine, 208 (3) pp. 230-231. Peer-reviewed.
 
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis.
Lamoth F., Nucci M., Fernandez-Cruz A., Azoulay E., Lanternier F., Bremerich J., Einsele H., Johnson E., Lehrnbecher T., Mercier T. et al., 2023/07/06. Medical mycology, 61 (7). Peer-reviewed.
Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
Filippidis P., Damas J., Viala B., Assal F., Nawej Tshikung O., Tarr P., Derfuss T., Oberholzer M., Jelcic I., Hundsberger T. et al., 2023/07/01. Journal of acquired immune deficiency syndromes, 93 (3) pp. 219-228. Peer-reviewed.
Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazole.
Haefliger D., Marzolini C., Lamoth F., Pabst T., Buclin T., Livio F., 2023/07. British journal of clinical pharmacology, 89 (7) pp. 2304-2308. Peer-reviewed.
 
Which trial do we need? Culture of preservation fluid in abdominal organ transplant recipients.
Manuel O., van den Bogaart L., Mueller N.J., Neofytos D., 2023/07. Clinical microbiology and infection, 29 (7) pp. 832-834. Peer-reviewed.
Barriers and facilitators to implementation of point-of-care lung ultrasonography in a tertiary centre in Benin: a qualitative study among general physicians and pneumologists.
Suttels V., Guedes Da Costa S., Garcia E., Brahier T., Hartley M.A., Agodokpessi G., Wachinou P., Fasseur F., Boillat-Blanco N., 2023/06/26. BMJ open, 13 (6) pp. e070765. Peer-reviewed.
 
Applications de la méditation de pleine conscience dans différents secteurs de médecine somatique. Un outil de gestion de la douleur physique et morale [Mindfulness meditation in somatic medicine. A management tool for physical and psychological pain]
Stanic J., Jackson-Perry D., Courvoisier C., Gaignard M.E., Dunker Scheuner D., Jeker Frésard E., Grabherr L., Berna C., 2023/06/21. Revue medicale suisse, 19 (832) pp. 1228-1233. Peer-reviewed.
Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study.
Avery E.F., Kleynhans J.N., Ledergerber B., Schoepf I.C., Thorball C.W., Kootstra N.A., Reiss P., Ryom L., Braun D.L., Thurnheer M.C. et al., 2023/06/08. Clinical infectious diseases, 76 (11) pp. 1969-1979. Peer-reviewed.
Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update.
Neofytos D., Stampf S., Hoessly L.D., D'Asaro M., Tang G.N., Boggian K., Hirzel C., Khanna N., Manuel O., Mueller N.J. et al., 2023/06. Open forum infectious diseases, 10 (6) pp. ofad247. Peer-reviewed.
Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines.
Ekobena P., Rothuizen L.E., Bedussi F., Guilcher P., Meylan S., Ceschi A., Girardin F., Dao K., 2023/06. International journal of audiology, 62 (6) pp. 587-591. Peer-reviewed.
 
Highlights of the first edition of the European Conference on Microbiota & Virology: A hybrid event, Paris, 23 March 2023
Psomas Christina K., Serrano-Villar Sergio, Guery Benoit, Halfon Philippe, Marchetti Giulia, 2023/06. Journal of Virus Eradication, 9 (2) p. 100332.
 
Novel Approaches in the Management of Mucormycosis
Lamoth Frederic, 2023/06. Current Fungal Infection Reports, 17 (2) pp. 98-107.
One for all, all for one: neuro-HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV.
Damas J., Darling KEA, Bidlingmeyer P., Nadin-Debluë I., Bieler M., Vollino L., Sokolov A.A., Berney A., Maccaferri G., Filippidis P. et al., 2023/06. HIV medicine, 24 (6) pp. 738-748. Peer-reviewed.
Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration.
Thoueille P., Alves Saldanha S., Desfontaine V., Kusejko K., Courlet P., Andre P., Cavassini M., Decosterd L.A., Buclin T., Guidi M. et al., 2023/06/01. The Journal of antimicrobial chemotherapy, 78 (6) pp. 1433-1443. Peer-reviewed.
 
Potential for improvement in governance and national action plans to overcome antimicrobial resistance.
Cassini A., Tacconelli E., 2023/06. The Lancet. Infectious diseases, 23 (6) pp. 640-642. Peer-reviewed.
 
Solid organ transplantation: Need of a new paradigm integrating biological sex.
Rello J., Manuel O., Pont T., 2023/06. European journal of internal medicine, 112 p. 117. Peer-reviewed.
Things We Do for No Reason™: Computed tomography of the head before lumbar puncture in low-risk adults and children.
Regina J., Manuel O., 2023/06. Journal of hospital medicine, 18 (6) pp. 534-537. Peer-reviewed.
Dry alginate beads for fecal microbiota transplantation: From model strains to fecal samples.
Rakotonirina A., Galperine T., Audry M., Kroemer M., Baliff A., Carrez L., Sadeghipour F., Schrenzel J., Guery B., Allémann E., 2023/05/25. International journal of pharmaceutics, 639 p. 122961. Peer-reviewed.
 
Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX3.
Porte R., Silva-Gomes R., Theroude C., Parente R., Asgari F., Sironi M., Pasqualini F., Valentino S., Asselta R., Recordati C. et al., 2023/05/24. eLife, 12 pp. e78601. Peer-reviewed.
Exploration of the Acceptance of the Use of Procalcitonin Point-of-Care Testing and Lung Ultrasonography by General Practitioners to Decide on Antibiotic Prescriptions for Lower Respiratory Infections: A Qualitative Study.
Geis D., Canova N., Lhopitallier L., Kronenberg A., Meuwly J.Y., Senn N., Mueller Y., Fasseur F., Boillat-Blanco N., 2023/05/11. BMJ open, 13 (5) pp. e063922. Peer-reviewed.
 
Leptospirose, le défi diagnostique d’un cas autochtone [Leptospirosis, the diagnostic challenge of an indigenous case]
Martelli F., Gay Des Combes Gliven P., De Vallière S., Favrat B., Greub G., Kokkinakis I., 2023/05/10. Revue medicale suisse, 19 (826) pp. 916-919. Peer-reviewed.
 
Utilité du TDM des anti-rétroviraux: passé, présent, futur
Choong Eva, Thoueille Paul, Cavassini M., Decosterd Laurent, 2023/05/04. dans Association pour la ormation en Analyses de Biologie Spécialisée (AFABS) - Journée de formation du 4 mai 2023 - Lausanne . Peer-reviewed.
 
Associated deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland, 2010 to 2019.
Gasser M., Cassini A., Lo Fo Wong D., Gelormini M., Nahrgang S.A., Zingg W., Kronenberg A.O., 2023/05. Euro surveillance, 28 (20) p. 2200532. Peer-reviewed.
 
Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression.
Castillo-Mancilla J.R., Morrow M., Hunt P.W., Schnittman S.R., Phillips A.N., Baker J.V., Haberer J.E., Janeiro M.J., Aragao F., Cohen C. et al., 2023/05. Open forum infectious diseases, 10 (5) pp. ofad230. Peer-reviewed.
Comparison of five different risk scores to predict incident type 2 diabetes in the Swiss HIV cohort study.
Blondet F., Kraege V., Cavassini M., Damas Fernandez J., Vollenweider P., Wandeler G., Hoffman M., Calmy A., Stoeckle M., Bernasconi E. et al., 2023/05/01. AIDS, 37 (6) pp. 935-939. Peer-reviewed.
 
Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years.
Schoepf I.C., Esteban-Cantos A., Thorball C.W., Rodés B., Reiss P., Rodríguez-Centeno J., Riebensahm C., Braun D.L., Marzolini C., Seneghini M. et al., 2023/05. The lancet. Healthy longevity, 4 (5) pp. e211-e218. Peer-reviewed.
 
Novel ERG11 and TAC1b mutations associated with azole resistance in Candida auris.
Li J., Coste A.T., Liechti M., Bachmann D., Sanglard D., Lamoth F., 2023/05/01. Antimicrobial agents and chemotherapy, 65 (5) pp. e02663-20. Peer-reviewed.
The Swiss Pathogen Surveillance Platform - towards a nation-wide One Health data exchange platform for bacterial, viral and fungal genomics and associated metadata.
Neves A., Walther D., Martin-Campos T., Barbie V., Bertelli C., Blanc D., Bouchet G., Erard F., Greub G., Hirsch H.H. et al., 2023/05. Microbial genomics, 9 (5). Peer-reviewed.
 
Insights into Antimicrobial and Anti-Inflammatory Applications of Plant Bioactive Compounds.
Mitropoulou G., Stavropoulou E., Vaou N., Tsakris Z., Voidarou C., Tsiotsias A., Tsigalou C., Taban B.M., Kourkoutas Y., Bezirtzoglou E., 2023/04/28. Microorganisms, 11 (5) p. 1156. Peer-reviewed.
 
Troubles cognitifs chez les personnes vivant avec le VIH. L’importance d’une prise en charge multidisciplinaire [Multidisciplinary assessment and management of neurocognitive complaints in people living with HIV]
Damas J., Berney A., Bieler-Aeschlimann M., Cavassini M., Du Pasquier R., 2023/04/26. Revue medicale suisse, 19 (824) pp. 797-799. Peer-reviewed.
 
Complex Lemierre syndrome with multisystemic abscesses.
Bourgeaud J., Delabays B., Van den Bogaart L., Ratano D., 2023/04/21. BMJ case reports, 16 (4) pp. e254638. Peer-reviewed.
Circulating proteins to predict COVID-19 severity.
Su C.Y., Zhou S., Gonzalez-Kozlova E., Butler-Laporte G., Brunet-Ratnasingham E., Nakanishi T., Jeon W., Morrison D.R., Laurent L., Afilalo J. et al., 2023/04/17. Scientific reports, 13 (1) p. 6236. Peer-reviewed.
 
Brief Report: Does Menopause Transition Influence Viral Suppression and Adherence in Women Living With HIV?
Hachfeld A., Atkinson A., Stute P., Calmy A., Tarr P.E., Darling KEA, Babouee Flury B., Polli C., Sultan-Beyer L., Abela I.A. et al., 2023/04/15. Journal of acquired immune deficiency syndromes, 92 (5) pp. 399-404. Peer-reviewed.
 
Le retour d’une vieille compagne
Kaiser L., Kaufmann D., 2023/04/12. Revue medicale suisse, 19 (822) pp. 699-700. Peer-reviewed.
 
Nouveautés dans la prise en charge de l’infection à cytomégalovirus chez les patients transplantés [Update on the management of cytomegalovirus infection in transplant recipients]
Neofytos D., Van Delden C., Manuel O., 2023/04/12. Revue medicale suisse, 19 (822) pp. 726-730. Peer-reviewed.
 
Réponses innovantes pour faire face aux enjeux liés au VIH dans un hôpital universitaire en Suisse [Innovative responses to HIV-related issues in a university hospital in Switzerland]
Cobos Manuel I., Courvoisier C., Rhis M.F., Depallens R., Buvelot Corthesy C., Muggli E., Cavassini M., Jackson-Perry D., 2023/04/12. Revue medicale suisse, 19 (822) pp. 732-735. Peer-reviewed.
 
Échinococcose alvéolaire : prise en charge en 2023 [2023 update on alveolar echinococcosis]
Gauthiez E., Uldry E., Coste A.T., Prior J., Cavassini M., Munting A., 2023/04/12. Revue medicale suisse, 19 (822) pp. 708-712. Peer-reviewed.
Long-Term Consequences of COVID-19: A 1-Year Analysis.
Bamps L., Armenti J.P., Bojan M., Grandbastien B., von Garnier C., Du Pasquier R., Desgranges F., Papadimitriou-Olivgeris M., Alberio L., Preisig M. et al., 2023/04/03. Journal of clinical medicine, 12 (7) p. 2673. Peer-reviewed.
Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland.
Walti L.N., Mugglin C., Mombelli M., Manuel O., Hirsch H.H., Khanna N., Mueller N.J., Berger C., Boggian K., Garzoni C. et al., 2023/04/03. JAMA network open, 6 (4) pp. e2310687. Peer-reviewed.
18F-FDG-PET/CT as part of the diagnostic workup of native valve endocarditis: A case report.
Corby-Zauner C., Monney P., Papadimitriou-Olivgeris M., Prior J.O., Kamani C.H., 2023/04. Journal of nuclear cardiology, 30 (2) pp. 823-825. Peer-reviewed.
Successful implementation of new Swiss recommendations on breastfeeding of infants born to women living with HIV.
Crisinel P.A., Kusejko K., Kahlert C.R., Wagner N., Beyer L.S., De Tejada B.M., Hösli I., Vasconcelos M.K., Baumann M., Darling K. et al., 2023/04. European journal of obstetrics, gynecology, and reproductive biology, 283 pp. 86-89. Peer-reviewed.
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4<sup>+</sup> T cell profile.
Sannier G., Nicolas A., Dubé M., Marchitto L., Nayrac M., Tastet O., Chatterjee D., Tauzin A., Lima-Barbosa R., Laporte M. et al., 2023/03/21. Cell reports. Medicine, 4 (3) p. 100955. Peer-reviewed.
Prospective compliance assessment of surgical site infection prevention measures in colorectal surgery.
Deslarzes P., Jurt J., Hübner M., Hahnloser D., Clerc D., Senn L., Demartines N., Grass F., 2023/03/07. BJS open, 7 (2). Peer-reviewed.
 
Rectal shedding of monkeypox virus in a patient coinfected with Chlamydia trachomatis and Neisseria gonorrhoeae: a case report.
Desgranges F., Glampedakis E., Christinet V., Encarnação S., Fernandes C., Greub G., Opota O., Cavassini M., 2023/03/06. Journal of medical case reports, 17 (1) p. 94. Peer-reviewed.
 
Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1.
Balakrishna S., Loosli T., Zaheri M., Frischknecht P., Huber M., Kusejko K., Yerly S., Leuzinger K., Perreau M., Ramette A. et al., 2023/03/02. The Journal of antimicrobial chemotherapy, 78 (3) pp. 656-664. Peer-reviewed.
Pulse Oximetry as an Aid to Rule Out Pneumonia among Patients with a Lower Respiratory Tract Infection in Primary Care.
Fischer C., Knüsli J., Lhopitallier L., Tenisch E., Meuwly M.G., Douek P., Meuwly J.Y., D'Acremont V., Kronenberg A., Locatelli I. et al., 2023/03/02. Antibiotics, 12 (3) p. 496. Peer-reviewed.
 
A Functional Polymorphism in IL-1B Is Associated With Immune Reconstitution Inflammatory Syndrome of Chronic Disseminated Candidiasis.
Rammaert B., Bochud P.Y., Brunel A.S., Wojtowicz A., Candon S., Gallego Hernanz M.P., Lortholary O., 2023/03. Open forum infectious diseases, 10 (3) pp. ofad078. Peer-reviewed.
Clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteraemia.
Papadimitriou-Olivgeris M., Jacot D., Senn L., Guery B., 2023/03. European journal of clinical microbiology & infectious diseases, 42 (3) pp. 379-382. Peer-reviewed.
Predictors of mortality of Staphylococcus aureus bacteremia among patients hospitalized in a Swiss University Hospital and the role of early source control; a retrospective cohort study.
Papadimitriou-Olivgeris M., Caruana G., Senn L., Guery B., 2023/03. European journal of clinical microbiology & infectious diseases, 42 (3) pp. 347-357. Peer-reviewed.
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study).
Pascale R., Toschi A., Aslan A.T., Massaro G., Maccaro A., Fabbricatore D., Dell'Aquila A., Ripa M., Işık M.E., Kızmaz Y.U. et al., 2023/03. International journal of antimicrobial agents, 61 (3) p. 106734. Peer-reviewed.
 
The effect of sex inequality on solid organ transplantation: A systematic review and meta-analysis.
Tejada S., Martinez-Reviejo R., Nogueira T.A., Gómez A., Pont T., Liao X., Zhang Z., Manuel O., Rello J., 2023/03. European journal of internal medicine, 109 pp. 58-67. Peer-reviewed.
 
What Is New in Pulmonary Mucormycosis?
Danion F., Coste A., Le Hyaric C., Melenotte C., Lamoth F., Calandra T., Garcia-Hermoso D., Aimanianda V., Lanternier F., Lortholary O., 2023/02/28. Journal of fungi, 9 (3) p. 307. Peer-reviewed.
 
Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units.
Kritikos A., Caruana G., Poissy J., Mamin A., Bachmann D., Pagani J.L., Coste A.T., Lamoth F., 2023/02/22. Journal of clinical microbiology, 61 (2) pp. e0169122. Peer-reviewed.
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer.
Maertens J., Lodewyck T., Donnelly J.P., Chantepie S., Robin C., Blijlevens N., Turlure P., Selleslag D., Baron F., Aoun M. et al., 2023/02/18. Clinical infectious diseases, 76 (4) pp. 674-682. Peer-reviewed.
 
Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection.
Hofmann E., Surial B., Boillat-Blanco N., Günthard H.F., Stöckle M., Bernasconi E., Schmid P., Calmy A., Suter-Riniker F., Rauch A. et al., 2023/02/18. Clinical infectious diseases, 76 (4) pp. 730-733. Peer-reviewed.
 
Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial.
Cobuccio L.G., Laurent M., Gardiol C., Wampfler R., Poppert S., Senn N., Eperon G., Genton B., Locatelli I., de Vallière S., 2023/02/18. Journal of travel medicine, 30 (1) pp. taac143. Peer-reviewed.
 
Quantifying and Predicting Ongoing Human Immunodeficiency Virus Type 1 Transmission Dynamics in Switzerland Using a Distance-Based Clustering Approach.
Labarile M., Loosli T., Zeeb M., Kusejko K., Huber M., Hirsch H.H., Perreau M., Ramette A., Yerly S., Cavassini M. et al., 2023/02/14. The Journal of infectious diseases, 227 (4) pp. 554-564. Peer-reviewed.
 
Overruling of Procalcitonin-Guided Antibiotics for Lower Respiratory Tract Infections in Primary Care: Ancillary Study of a Randomized Controlled Trial.
Knüsli J., Lhopitallier L., Kronenberg A., Meuwly J.Y., Opota O., Perrenoud M.A., Page M.A., Kain K.C., Mamin A., D'Acremont V. et al., 2023/02/12. Antibiotics, 12 (2) p. 377. Peer-reviewed.
Diagnostic Performance of Individual Symptoms to Predict SARS-CoV-2 RT-PCR Positivity and Symptom Persistence among Suspects Presenting in Primary Care during the First Wave of COVID-19.
Savoy M., Kopp B., Chaouch A., Cohidon C., Gouveia A., Lombardo P., Maeder M., Payot S., Perdrix J., Schwarz J. et al., 2023/02/10. Infectious disease reports, 15 (1) pp. 112-124. Peer-reviewed.
Honey's Antioxidant and Antimicrobial Properties: A Bibliometric Study.
Stefanis C., Stavropoulou E., Giorgi E., Voidarou C.C., Constantinidis T.C., Vrioni G., Tsakris A., 2023/02/08. Antioxidants, 12 (2) p. 414. Peer-reviewed.
 
Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study.
Mejia-Chew C., Carver P.L., Rutjanawech S., Camargo LFA, Fernandes R., Belga S., Daniels S.A., Müller N.J., Burkhard S., Theodoropoulos N.M. et al., 2023/02/08. Clinical infectious diseases, 76 (3) pp. e995-e1003. Peer-reviewed.
 
A narrative review of the intermediate category of the antimicrobial susceptibility test: relation with dosing and possible impact on antimicrobial stewardship.
Yusuf E., Zeitlinger M., Meylan S., 2023/02/01. The Journal of antimicrobial chemotherapy, 78 (2) pp. 338-345. Peer-reviewed.
 
Author Correction: Transmission of trained immunity and heterologous resistance to infections across generations.
Katzmarski N., Domínguez-Andrés J., Cirovic B., Renieris G., Ciarlo E., Le Roy D., Lepikhov K., Kattler K., Gasparoni G., Händler K. et al., 2023/02..
 
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection.
Krutova M., Davis K., Guery B., Barbut F., 2023/02. The lancet. Gastroenterology & hepatology, 8 (2) pp. 111-112. Peer-reviewed.
Female Genital Mutilation/Cutting in the Swiss HIV Cohort Study: A Cross-Sectional Study.
Mauri F., Cottler-Casanova S., Cavassini M., Stoeckle M., Wandeler G., Schmid P., Braun D.L., Scherrer A., Bernasconi E., Calmy A. et al., 2023/02. Journal of immigrant and minority health, 25 (1) pp. 136-141. Peer-reviewed.
 
Outcomes of SARS-CoV-2 infection among lung transplant recipients: A single center retrospective study.
Casutt A., Papadimitriou-Olivgeris M., Ioakeim F., Aubert J.D., Manuel O., Koutsokera A., 2023/02. Transplant infectious disease, 25 (1) pp. e14007. Peer-reviewed.
 
Triggers of Change in Sexual Behavior Among People With HIV: The Swiss U U Statement and COVID-19 Compared.
Hamusonde K., Nicca D., Gnthard H.F., Stckle M., Darling KEA, Calmy A., Bernasconi E., Haerry D., Schmid P., Kouyos R.D. et al., 2023/02/01. The Journal of infectious diseases, 227 (3) pp. 407-411. Peer-reviewed.
 
VIH : zoom sur les traitements injectables à longue durée d’action [News in HIV infection, long-acting injectable treatments]
Nawej Tshikung O., Segeral O., Cavassini M., Calmy A., 2023/02/01. Revue medicale suisse, 19 (812) pp. 243-249. Peer-reviewed.
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine.
Tauzin A., Nicolas A., Ding S., Benlarbi M., Medjahed H., Chatterjee D., Dionne K., Gong S.Y., Gendron-Lepage G., Bo Y. et al., 2023/01/31. Cell reports, 42 (1) p. 111998. Peer-reviewed.
Humoral Responses against BQ.1.1 Elicited after Breakthrough Infection and SARS-CoV-2 mRNA Vaccination.
Tauzin A., Benlarbi M., Medjahed H., Grégoire Y., Perreault J., Gendron-Lepage G., Gokool L., Morrisseau C., Arlotto P., Tremblay C. et al., 2023/01/21. Vaccines, 11 (2) p. 242. Peer-reviewed.
An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells.
Nicolas A., Sannier G., Dubé M., Nayrac M., Tauzin A., Painter M.M., Goel R.R., Laporte M., Gendron-Lepage G., Medjahed H. et al., 2023/01/20. iScience, 26 (1) p. 105904. Peer-reviewed.
Microbial Community Structure among Honey Samples of Different Pollen Origin.
Stavropoulou E., Remmas N., Voidarou C.C., Vrioni G., Konstantinidis T., Ntougias S., Tsakris A., 2023/01/06. Antibiotics, 12 (1) p. 101. Peer-reviewed.
Alterations of gut microbiome following gastrointestinal surgical procedures and their potential complications.
Tsigalou C., Paraschaki A., Bragazzi N.L., Aftzoglou K., Bezirtzoglou E., Tsakris Z., Vradelis S., Stavropoulou E., 2023. Frontiers in cellular and infection microbiology, 13 p. 1191126. Peer-reviewed.
Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity.
Pfefferlé M., Dubach I.L., Buzzi R.M., Dürst E., Schulthess-Lutz N., Baselgia L., Hansen K., Imhof L., Koernig S., Le Roy D. et al., 2023/01. Journal for immunotherapy of cancer, 11 (1) pp. e005718. Peer-reviewed.
 
Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?
Bestard O., Kaminski H., Couzi L., Fernández-Ruiz M., Manuel O., 2023. Transplant international, 36 p. 11963. Peer-reviewed.
Cytomegalovirus in donors for fecal microbiota transplantation, the phantom menace?
Galpérine T., Engelmann I., Hantz S., Postil D., Dewilde A., Deplanque D., Martin R., Labreuche J., Lazrek M., Somers S. et al., 2023. PloS one, 18 (6) pp. e0287847. Peer-reviewed.
Dysregulated monocyte-derived macrophage response to Group B Streptococcus in newborns.
Ravi D., Ntinopoulou E., Guetta N., Weier M., Vogel V., Spellerberg B., Sendi P., Gremlich S., Roger T., Giannoni E., 2023. Frontiers in immunology, 14 p. 1268804. Peer-reviewed.
Editorial: Beneficial and pathological roles of myeloid cells during COVID-19.
Sharma L., Sengupta S., Roger T., 2023. Frontiers in immunology, 14 p. 1194826. Peer-reviewed.
Novel Therapeutic Approaches to Invasive Candidiasis: Considerations for the Clinician.
Lamoth F., 2023. Infection and drug resistance, 16 pp. 1087-1097. Peer-reviewed.
 
Plasma SARS-CoV-2 RNA elimination and RAGE kinetics distinguish COVID-19 severity.
Deng X., Gantner P., Forestell J., Pagliuzza A., Brunet-Ratnasingham E., Durand M., Kaufmann D.E., Chomont N., Craig M., 2023. Clinical & translational immunology, 12 (11) pp. e1468. Peer-reviewed.
SARS-CoV-2 neutralizing antibody response in vaccinated and non-vaccinated hospital healthcare workers with or without history of infection.
Jacot D., von Rotz U., Pellaton C., Blondet F., Aebischer O., Perreau M., De Rham M., Pantaleo G., Marchetti O., Greub G., 2023. Microbes and infection, 25 (1-2) p. 105077. Peer-reviewed.
Sepsis awareness and knowledge amongst nurses, physicians and paramedics of a tertiary care center in Switzerland: A survey-based cross-sectional study.
Regina J., Le Pogam M.A., Niemi T., Akrour R., Pepe S., Lehn I., Wasserfallen J.B., Calandra T., Meylan S., 2023. PloS one, 18 (6) pp. e0285151. Peer-reviewed.
Swiss Sepsis National Action Plan: A coordinated national action plan to stop sepsis-related preventable deaths and to improve the support of people affected by sepsis in Switzerland.
Schlapbach L.J., Zimmermann E.A., Meylan S., Stocker M., Suter P.M., Jakob S.M., National Action Plan Working Group OBOTSS, 2023. Frontiers in medicine, 10 p. 1114546. Peer-reviewed.
The potential clinical value of pairing procalcitonin and lung ultrasonography to guide antibiotic therapy in patients with community-acquired pneumonia: a narrative review.
Bessat C., Boillat-Blanco N., Albrich W.C., 2023. Expert review of respiratory medicine, 17 (10) pp. 919-927. Peer-reviewed.
Échinococcose alvéolaire chez les receveurs d'une greffe d'organe solide : une série de cas de deux cohortes nationales [Alveolar echinococcosis in solid organ transplant recipients: a case series from two national cohorts]
Marquis B., Demonmerot F., Richou C., Thiéfin G., Millon L., Wallon M., Vuitton D.A., Grall-Jezequel A., Grenouillet F., Epaulard O. et al., 2023. Parasite, 30 p. 9. Peer-reviewed.
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations.
Mitropoulou G., Koutsokera A., Csajka C., Blanchon S., Sauty A., Brunet J.F., von Garnier C., Resch G., Guery B., 2022/12/31. European respiratory review, 31 (166) p. 220121. Peer-reviewed.
Pulmonary aspergillosis: diagnosis and treatment.
Lamoth F., Calandra T., 2022/12/31. European respiratory review, 31 (166) p. 220114. Peer-reviewed.
Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital.
Munting A., Damas J., Viala B., Prod'hom G., Guery B., Senn L., 2022/12/30. Antimicrobial resistance and infection control, 11 (1) p. 165. Peer-reviewed.
 
Factors Influencing the Implementation of Antimicrobial Stewardship in Primary Care: A Narrative Review.
Suttels V., Van Singer M., Clack L.C., Plüss-Suard C., Niquille A., Mueller Y., Boillat Blanco N., 2022/12/24. Antibiotics, 12 (1) p. 30. Peer-reviewed.
 
Parallel Evolution of Pseudomonas aeruginosa during a Prolonged ICU-Infection Outbreak.
Cameron D.R., Pitton M., Oberhaensli S., Schlegel K., Prod'hom G., Blanc D.S., Jakob S.M., Que Y.A., 2022/12/21. Microbiology spectrum, 10 (6) pp. e0274322. Peer-reviewed.
ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol.
Kotsaki A., Pickkers P., Bauer M., Calandra T., Lupse M., Wiersinga W.J., Meylan S., Bloos F., van der Poll T., Slim M.A. et al., 2022/12/20. BMJ open, 12 (12) pp. e067251. Peer-reviewed.
CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study.
Chammartin F., Darling K., Abela I.A., Battegay M., Furrer H., Calmy A., Bernasconi E., Schmid P., Hoffmann M., Bucher H.C. et al., 2022/12/15. Journal of acquired immune deficiency syndromes, 91 (5) p. 508. Peer-reviewed.
Prise en charge multidisciplinaire des infections de fracture [Multidisciplinary approach to fracture-related infection]
Muller Q., Gerber F., Papadimitriou Olivgeris M., Di Summa P., Boillat Blanco N., Steinmetz S., 2022/12/14. Revue medicale suisse, 18 (808) pp. 2363-2370. Peer-reviewed.
The Role of the Microbiome in Connective-Tissue-Associated Interstitial Lung Disease and Pulmonary Vasculitis.
Drakopanagiotakis F., Stavropoulou E., Tsigalou C., Nena E., Steiropoulos P., 2022/12/09. Biomedicines, 10 (12) p. 3195. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University